316 related articles for article (PubMed ID: 21438010)
1. Differentiation of induced pluripotent stem cells into functional oligodendrocytes.
Czepiel M; Balasubramaniyan V; Schaafsma W; Stancic M; Mikkers H; Huisman C; Boddeke E; Copray S
Glia; 2011 Jun; 59(6):882-92. PubMed ID: 21438010
[TBL] [Abstract][Full Text] [Related]
2. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro.
Tokumoto Y; Ogawa S; Nagamune T; Miyake J
J Biosci Bioeng; 2010 Jun; 109(6):622-8. PubMed ID: 20471604
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
4. Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells.
Onorati M; Camnasio S; Binetti M; Jung CB; Moretti A; Cattaneo E
Mol Cell Neurosci; 2010 Mar; 43(3):287-95. PubMed ID: 20026276
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells.
Yamashita T; Miyamoto Y; Bando Y; Ono T; Kobayashi S; Doi A; Araki T; Kato Y; Shirakawa T; Suzuki Y; Yamauchi J; Yoshida S; Sato N
PLoS One; 2017; 12(2):e0171947. PubMed ID: 28192470
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
7. The generation of iPS cells using non-viral magnetic nanoparticle based transfection.
Lee CH; Kim JH; Lee HJ; Jeon K; Lim H; Choi Hy; Lee ER; Park SH; Park JY; Hong S; Kim S; Cho SG
Biomaterials; 2011 Oct; 32(28):6683-91. PubMed ID: 21683440
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of oligodendrocytes from lineage-selectable embryonic stem cells in vitro.
Billon N; Jolicoeur C; Raff M
Methods Mol Biol; 2006; 330():15-32. PubMed ID: 16846014
[TBL] [Abstract][Full Text] [Related]
9. Derivation of induced pluripotent stem cells from human peripheral circulating T cells.
Seki T; Yuasa S; Fukuda K
Curr Protoc Stem Cell Biol; 2011 Sep; Chapter 4():Unit4A.3. PubMed ID: 21913170
[TBL] [Abstract][Full Text] [Related]
10. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
Mothe AJ; Tator CH
Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
[TBL] [Abstract][Full Text] [Related]
11. Immunopanning selection of A2B5-positive cells increased the differentiation efficiency of induced pluripotent stem cells into oligodendrocytes.
Ogawa S; Tokumoto Y; Miyake J; Nagamune T
Neurosci Lett; 2011 Feb; 489(2):79-83. PubMed ID: 21134419
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
Nakagawa M; Koyanagi M; Tanabe K; Takahashi K; Ichisaka T; Aoi T; Okita K; Mochiduki Y; Takizawa N; Yamanaka S
Nat Biotechnol; 2008 Jan; 26(1):101-6. PubMed ID: 18059259
[TBL] [Abstract][Full Text] [Related]
13. Highly efficient generation of definitive endoderm lineage from human induced pluripotent stem cells.
Sekine K; Takebe T; Suzuki Y; Kamiya A; Nakauchi H; Taniguchi H
Transplant Proc; 2012 May; 44(4):1127-9. PubMed ID: 22564643
[TBL] [Abstract][Full Text] [Related]
14. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
[TBL] [Abstract][Full Text] [Related]
15. Role of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts.
Chen M; Sun X; Jiang R; Shen W; Zhong X; Liu B; Qi Y; Huang B; Xiang AP; Ge J
Cell Biol Int; 2009 Dec; 33(12):1268-73. PubMed ID: 19524692
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
López-González R; Velasco I
Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
[TBL] [Abstract][Full Text] [Related]
17. Directing human neural stem/precursor cells into oligodendrocytes by overexpression of Olig2 transcription factor.
Maire CL; Buchet D; Kerninon C; Deboux C; Baron-Van Evercooren A; Nait-Oumesmar B
J Neurosci Res; 2009 Nov; 87(15):3438-46. PubMed ID: 19739249
[TBL] [Abstract][Full Text] [Related]
18. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue.
Chen SJ; Chang CM; Tsai SK; Chang YL; Chou SJ; Huang SS; Tai LK; Chen YC; Ku HH; Li HY; Chiou SH
Stem Cells Dev; 2010 Nov; 19(11):1757-67. PubMed ID: 20192839
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of polysialylated neural cell adhesion molecule improves the migration capacity of induced pluripotent stem cell-derived oligodendrocyte precursors.
Czepiel M; Leicher L; Becker K; Boddeke E; Copray S
Stem Cells Transl Med; 2014 Sep; 3(9):1100-9. PubMed ID: 25069776
[TBL] [Abstract][Full Text] [Related]
20. An improved method for generating and identifying human induced pluripotent stem cells.
Mali P; Ye Z; Chou BK; Yen J; Cheng L
Methods Mol Biol; 2010; 636():191-205. PubMed ID: 20336524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
